Rescheduling Could Raise 7-OH Withdrawal Risk in PA

Pennsylvanians who use 7-OH or kratom products may see more withdrawal and overdose risk once federal rules take effect.

Updated on Nov. 7, 2026 in Substance Abuse

Rescheduling Could Raise 7-OH Withdrawal Risk in PA

Live Poll

Should the federal government ban kratom-derived products like 7-OH?

The Pennsylvania Department of Health has warned of an expected rise in opioid withdrawal patients ahead of the federal Drug Enforcement Administration's planned rescheduling of 7-OH, a kratom-derived substance, as a Schedule I controlled substance. The rescheduling, which is slated to take effect in the coming days, would also cover MGM-15, MGM-16, and tianeptine.

Why it matters

Pennsylvania health officials are concerned that removing legal access to 7-OH could push people who use it toward street supplies or other illicit drugs, raising overdose risk. The state's data show 7-OH has already been tied to dozens of overdose deaths each year, making the timing of the federal action a practical public health question for residents who use these products.

The figures come from Pennsylvania overdose death records and poison control center exposure reports covering 2022 through mid-2026. Overdose deaths attributed to 7-OH fell from 65 in 2023 to 33 in 2025, while poison control cases show a subset of exposures involved serious illness, Narcan use, or ventilation.

The players

Pennsylvania Department of Health

The state agency responsible for public health protection, disease surveillance, and overdose prevention across Pennsylvania.

Drug Enforcement Administration

The federal agency that enforces controlled substance laws and sets scheduling classifications for drugs under the Controlled Substances Act.

WVU Health System

A West Virginia health system whose representative declined to comment on the rescheduling's expected effects on patients.

The details

7-OH is a substance that produces effects similar to opioids and occurs naturally in only very small amounts in the leaves of the kratom tree. Manufacturers have concentrated and synthesized 7-OH derivatives into tablets, gummies, and drink mixes, which delivers a much stronger dose than the plant itself. Some laboratories have begun testing specifically for 7-OH and related compounds, though overdose data has not yet separated natural kratom from synthetic 7-OH.

Timeline

  1. 2023: 7-OH was linked to 65 overdose deaths in Pennsylvania.

  2. 2024: 7-OH was linked to 38 overdose deaths in Pennsylvania.

  3. 2025: 7-OH was linked to 33 overdose deaths in Pennsylvania.

  4. June 30, 2026: End of the poison control exposure recording period.

  5. November 13, 2026: Planned DEA rescheduling of 7-OH and related substances.

Health Landscape

Federal scheduling under the Controlled Substances Act is the mechanism being used to address concentrated kratom derivatives that have spread through retail markets. Overdose prevention efforts in Pennsylvania have increasingly had to account for non-opioid substances that act on the same receptors as opioids.

If you or someone you know uses 7-OH or kratom products, it is worth talking with a doctor before the rescheduling takes effect about what withdrawal could look like and what support options exist. Anyone who uses these products for pain management should discuss alternatives and plan for care with a clinician rather than changing use on their own.

The takeaway

Pennsylvania's data show 7-OH has been linked to dozens of overdose deaths each year, and the state expects rescheduling to bring more withdrawal cases. Anyone with questions about 7-OH, kratom, or withdrawal should raise them with a physician or local addiction treatment provider.

What happens next

The DEA's planned rescheduling of 7-OH, MGM-15, MGM-16, and tianeptine as Schedule I controlled substances is scheduled for November 13, 2026, after which changes in overdose and withdrawal patterns in Pennsylvania can be tracked.

Further reading

For more on how these substances affect people who use them, see our Substance Abuse coverage.

Source note: This article includes information reported by Butlereagle.

Live Poll

Should the federal government ban kratom-derived products like 7-OH?